XRAY · Dentsply Sirona Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $880.00M | - | $904.00M | $936.00M | $879.00M | - | $951.00M | $984.00M | $953.00M | - |
| Cost of Revenue | $453.00M | - | $463.00M | $446.00M | $413.00M | - | $456.00M | $473.00M | $447.00M | - |
| Gross Profit | $427.00M | - | $441.00M | $490.00M | $466.00M | - | $495.00M | $511.00M | $506.00M | - |
| R&D | $44.00M | - | $37.00M | $37.00M | $36.00M | - | $40.00M | $41.00M | $42.00M | - |
| SG&A | $351.00M | - | $355.00M | $342.00M | $358.00M | - | $390.00M | $399.00M | $415.00M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $79.00M | - | $89.00M | $86.00M | $86.00M | - | - | - | $32.00M | - |
| Operating Income | ($35.00M) | - | ($218.00M) | ($128.00M) | $63.00M | - | ($462.00M) | $50.00M | $42.00M | - |
| Interest Expense | $24.00M | - | $23.00M | $24.00M | $18.00M | - | $18.00M | $22.00M | $18.00M | - |
| Income Tax | ($32.00M) | - | $198.00M | ($109.00M) | $25.00M | - | $17.00M | $38.00M | $14.00M | - |
| Net Income | ($10.00M) | - | ($427.00M) | ($45.00M) | $20.00M | - | ($494.00M) | ($4.00M) | $18.00M | - |
| EPS - Basic | ($0.05) | - | ($2.14) | ($0.22) | $0.10 | - | ($2.46) | ($0.02) | $0.09 | - |
| EPS - Diluted | ($0.05) | - | ($2.14) | ($0.22) | $0.10 | - | ($2.46) | ($0.02) | $0.09 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190.00M | $326.00M | $363.00M | $359.00M | $398.00M | $272.00M | $296.00M | $279.00M | $291.00M | $334.00M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $659.00M | $642.00M | $686.00M | $675.00M | $612.00M | $564.00M | $619.00M | $608.00M | $613.00M | $624.00M |
| Accounts Payable | $259.00M | $300.00M | $268.00M | $268.00M | $276.00M | $241.00M | $297.00M | $287.00M | $279.00M | $305.00M |
| Current Assets | $1.84B | $2.02B | $2.07B | $1.97B | $1.98B | $1.75B | $1.92B | $1.76B | $1.90B | $1.97B |
| Total Assets | $5.23B | $5.43B | $5.65B | $6.07B | $6.05B | $5.75B | $6.63B | $6.90B | $7.12B | $7.37B |
| Current Liabilities | $1.21B | $1.34B | $1.41B | $1.17B | $1.79B | $1.59B | $1.54B | $1.32B | $1.33B | $1.43B |
| Long-term Debt | $2.01B | $2.02B | $2.02B | $2.22B | $1.59B | $1.59B | $1.79B | $1.74B | $1.75B | $1.80B |
| Total Liabilities | $3.91B | $4.09B | $4.17B | $4.11B | $4.04B | $3.81B | $4.14B | $3.83B | $3.87B | $4.08B |
| Stockholders' Equity | $1.32B | $1.34B | $1.48B | $1.96B | $2.01B | $1.94B | $2.49B | $3.06B | $3.26B | $3.29B |
| Retained Earnings | ($1.57B) | ($1.56B) | ($1.39B) | ($925.00M) | ($848.00M) | ($835.00M) | ($374.00M) | $152.00M | $190.00M | $205.00M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $40.00M | - | - | - | $7.00M | - | - | - | $25.00M | - |
| Investing Cash Flow | ($53.00M) | - | - | - | ($17.00M) | - | - | - | ($43.00M) | - |
| Financing Cash Flow | ($119.00M) | - | - | - | $123.00M | - | - | - | ($14.00M) | - |
| CapEx | $52.00M | - | - | - | $19.00M | - | - | - | $34.00M | - |
| Free Cash Flow | ($12.00M) | - | - | - | ($12.00M) | - | - | - | ($9.00M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 48.5% | - | 48.8% | 52.4% | 53.0% | - | 52.1% | 51.9% | 53.1% | - |
| Operating margin | -4.0% | - | -24.1% | -13.7% | 7.2% | - | -48.6% | 5.1% | 4.4% | - |
| EBITDA margin | 5.0% | - | -14.3% | -4.5% | 17.0% | - | - | - | 7.8% | - |
| Net margin | -1.1% | - | -47.2% | -4.8% | 2.3% | - | -51.9% | -0.4% | 1.9% | - |
| Free cash flow margin | -1.4% | - | - | - | -1.4% | - | - | - | -0.9% | - |
| FCF / Net income | 1.20 | - | - | - | -0.60 | - | - | - | -0.50 | - |
| R&D / Revenue | 5.0% | - | 4.1% | 4.0% | 4.1% | - | 4.2% | 4.2% | 4.4% | - |
| SG&A / Revenue | 39.9% | - | 39.3% | 36.5% | 40.7% | - | 41.0% | 40.5% | 43.5% | - |
| Effective tax rate | - | - | - | - | 55.6% | - | - | 111.8% | 43.8% | - |
| Return on assets | -0.2% | - | -7.6% | -0.7% | 0.3% | - | -7.5% | -0.1% | 0.3% | - |
| Return on equity | -0.8% | - | -28.9% | -2.3% | 1.0% | - | -19.8% | -0.1% | 0.6% | - |
| Return on invested capital | -0.8% | - | -4.9% | -2.4% | 0.9% | - | -8.5% | 0.5% | 0.5% | - |
| Liquidity | ||||||||||
| Current ratio | 1.53 | 1.51 | 1.47 | 1.69 | 1.10 | 1.10 | 1.25 | 1.33 | 1.43 | 1.38 |
| Quick ratio | 0.98 | 1.03 | 0.99 | 1.11 | 0.76 | 0.74 | 0.84 | 0.87 | 0.97 | 0.95 |
| Cash ratio | 0.16 | 0.24 | 0.26 | 0.31 | 0.22 | 0.17 | 0.19 | 0.21 | 0.22 | 0.23 |
| Leverage | ||||||||||
| Debt / Equity | 1.52 | 1.50 | 1.36 | 1.13 | 0.79 | 0.82 | 0.72 | 0.57 | 0.54 | 0.55 |
| Debt / Assets | 0.38 | 0.37 | 0.36 | 0.37 | 0.26 | 0.28 | 0.27 | 0.25 | 0.25 | 0.24 |
| Debt / EBITDA | 45.59 | - | - | - | 10.69 | - | - | - | 23.61 | - |
| Interest coverage | -1.5x | - | -9.5x | -5.3x | 3.5x | - | -25.7x | 2.3x | 2.3x | - |
| Equity multiplier | 3.97 | 4.05 | 3.82 | 3.10 | 3.01 | 2.96 | 2.66 | 2.25 | 2.19 | 2.24 |
| Liabilities / Assets | 0.75 | 0.75 | 0.74 | 0.68 | 0.67 | 0.66 | 0.62 | 0.56 | 0.54 | 0.55 |
| Efficiency | ||||||||||
| Asset turnover | 0.17 | - | 0.16 | 0.15 | 0.15 | - | 0.14 | 0.14 | 0.13 | - |
| Inventory turnover | 0.69 | - | 0.67 | 0.66 | 0.67 | - | 0.74 | 0.78 | 0.73 | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 531d | - | 541d | 552d | 541d | - | 495d | 469d | 501d | - |
| Days payable outstanding | 209d | - | 211d | 219d | 244d | - | 238d | 221d | 228d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | 149.4x | - | - | - | 368.8x | - |
| P / B | 1.8x | - | 1.7x | 1.6x | 1.5x | - | 2.2x | 1.7x | 2.1x | - |
| P / S | 2.6x | - | 2.8x | 3.4x | 3.4x | - | 5.7x | 5.2x | 7.3x | - |
| EV / EBITDA | 94.0x | - | - | - | 28.1x | - | - | - | 113.2x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.1% | - | -4.9% | -4.9% | -7.8% | - | 0.4% | -4.3% | -2.6% | - |
| Revenue CAGR (3y) | -3.5% | - | -1.5% | -2.9% | -3.2% | - | -3.8% | -2.7% | 2.9% | - |
| Revenue CAGR (5y) | 0.1% | - | 0.2% | 13.8% | - | - | - | - | - | - |
| Gross profit growth (YoY) | -8.4% | - | -10.9% | -4.1% | -7.9% | - | 0.0% | -7.1% | -2.5% | - |
| Operating income growth (YoY) | - | - | 52.8% | - | 50.0% | - | -95.8% | -37.5% | - | - |
| Net income growth (YoY) | - | - | 13.6% | -1025.0% | 11.1% | - | -85.7% | - | - | - |
| EPS growth (YoY) | - | - | 13.0% | -1000.0% | 11.1% | - | -96.8% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | -32.1% | - | - | - | -44.6% | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | -11.9% | - |
| FCF growth (YoY) | 0.0% | - | - | - | -33.3% | - | - | - | 85.0% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -34.4% | -31.1% | -40.7% | -36.0% | -38.3% | -41.0% | -26.2% | -17.3% | -10.5% | -13.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$3.68B totalEssential Dental Solutions$1.47B · 39.9%
Connected Technology Solutions$1.04B · 28.2%
Orthodontic And Implant Solutions$850.00M · 23.1%
Wellspect Healthcare$325.00M · 8.8%
Product / service
$1.89B totalImplants And Prosthetics$623.00M · 33.0%
Equipment And Instruments$578.00M · 30.6%
CADCAM$458.00M · 24.3%
Orthodontics$227.00M · 12.0%
Geographic
$6.18B totalOther Foreign$2.08B · 33.6%
Europe$1.58B · 25.5%
US$1.18B · 19.1%
Rest Of The World$922.00M · 14.9%
DE$422.00M · 6.8%
Peer comparison
Same SIC group: Dental Equipment & Supplies
Comparing DENTSPLY SIRONA Inc. against the 5 most active filers in the same SIC group.
Dividends
$0.48/share trailing 12 months · -25.0% YoY
| Ex-date | Per share |
|---|---|
| Dec 26, 2025 | $0.1600 |
| Sep 26, 2025 | $0.1600 |
| Jun 27, 2025 | $0.1600 |
| Mar 28, 2025 | $0.1600 |
| Dec 27, 2024 | $0.1600 |
| Sep 27, 2024 | $0.1600 |
| Jun 28, 2024 | $0.1600 |
| Mar 27, 2024 | $0.1600 |
| Dec 28, 2023 | $0.1400 |
| Sep 28, 2023 | $0.1400 |
| Jun 29, 2023 | $0.1400 |
| Mar 30, 2023 | $0.1400 |
| Dec 29, 2022 | $0.1250 |
| Sep 29, 2022 | $0.1250 |
| Jun 23, 2022 | $0.1250 |
| Mar 24, 2022 | $0.1250 |
| Dec 30, 2021 | $0.1100 |
| Sep 23, 2021 | $0.1100 |
| Jun 24, 2021 | $0.1100 |
| Mar 25, 2021 | $0.1000 |
| Dec 23, 2020 | $0.1000 |
| Sep 24, 2020 | $0.1000 |
| Jun 25, 2020 | $0.1000 |
| Mar 26, 2020 | $0.1000 |